Clinical Study Schedule of Activities
1.0.0 - trial-use International flag

This page is part of the Clinical Study Schedule of Activities (v1.0.0: STU1) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Credits

Credits

This Implementation Guide was developed under the auspices of the HL7 Vulcan Schedule of Activities work group, and builds on the unballoted IG work published previously Vulcan Schedule of Study Activities FHIR Implementation Guide.

Contributing individuals and organisations are:

Current work group co-chairs:

  • Michael Ward - TransCelerate Biopharma / Eli Lilly & Company
  • Geoff Low - Medidata/3DS

Core work group members:

  • Jean Duteau - Duteau Design
  • Rebecca Baker - CDISC
  • Andy Richardson - Zenetar
  • Rahul Thandavan - Roche
  • Jeffrey Abolofia - Pinnacle 21
  • Mike Hamidi - Pfizer
  • Hugh Glover - Bluewave Informatics/HL7 BR&R

Project Management:

  • Katie Warren PHUSE
  • Shani Sampson Vulcan
  • Michael Van Campen Vulcan

With contributions from other members who have from time to time, or quietly, participated in meetings, attended conference calls, and supported the core team during the development process.

If you are interested in participating in the Vulcan Schedule of Activities work group information about our calls, meetings and discussions can be found on HL7 Confluence pages here.